17-Jun-2026
OptimizeRx to Participate in Upcoming Investor Conferences
Globe Newswire (Mon, 1-Jun 7:30 AM ET)
DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx's Authenticated EHR Network
Globe Newswire (Thu, 21-May 7:30 AM ET)
OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Globe Newswire (Tue, 12-May 4:01 PM ET)
OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
Globe Newswire (Mon, 11-May 7:30 AM ET)
OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
Globe Newswire (Wed, 29-Apr 4:05 PM ET)
OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
Globe Newswire (Tue, 28-Apr 8:00 AM ET)
Myomo Appoints William J Febbo to its Board of Directors
Business Wire (Thu, 16-Apr 4:05 PM ET)
OptimizeRx Appoints Mary Varghese Presti to Board of Directors
Globe Newswire (Wed, 8-Apr 4:05 PM ET)
OptimizeRx Achieves Rule of 40 Status Amid Record 2025 Performance and $10 Million Share Buyback
Market Chameleon (Fri, 6-Mar 2:50 AM ET)
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Optimizerx trades on the NASDAQ stock market under the symbol OPRX.
As of June 17, 2026, OPRX stock price declined to $5.08 with 360,430 million shares trading.
OPRX has a beta of 2.61, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.21 to the broad based SPY ETF.
OPRX has a market cap of $93.93 million. This is considered a Micro Cap stock.
Last quarter Optimizerx reported $20 million in Revenue and $.14 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.16.
In the last 3 years, OPRX traded as high as $22.25 and as low as $3.78.
The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, IWM, VXF, IWO, KOMP.
OPRX has underperformed the market in the last year with a price return of -63.1% while the SPY ETF gained +24.2%. OPRX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.2% and -3.8%, respectively, while the SPY returned +11.0% and -2.5%, respectively.
OPRX support price is $5.07 and resistance is $5.49 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX shares will trade within this expected range on the day.